Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantSANOFI-AVENTIS SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
INTRAVENOUS
Medical Information
A16AB22
avalglucosidase alfa
Manufacturer Information
SANOFI-AVENTIS SINGAPORE PTE. LTD.
GENZYME IRELAND LIMITED
Active Ingredients
Documents
Package Inserts
Nexviazyme infusion PI.pdf
Approved: April 24, 2024